| Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels K Weston-Green, XF Huang, J Lian, C Deng European Neuropsychopharmacology 22 (5), 364-373, 2012 | 102 | 2012 |
| Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats M He, Q Zhang, C Deng, H Wang, J Lian, XF Huang Psychoneuroendocrinology 42, 153-164, 2014 | 91 | 2014 |
| Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model C Deng, J Lian, N Pai, XF Huang Journal of psychopharmacology 26 (9), 1271-1279, 2012 | 84 | 2012 |
| Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment J Lian, XF Huang, N Pai, C Deng PLoS One 9 (8), e104160, 2014 | 71 | 2014 |
| Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways J Lian, XF Huang, N Pai, C Deng Psychoneuroendocrinology 48, 77-86, 2014 | 69 | 2014 |
| Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats Q Zhang, J Lian, M He, C Deng, H Wang, XF Huang Progress in Neuro-Psychopharmacology and Biological Psychiatry 51, 172-180, 2014 | 61 | 2014 |
| Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats Q Zhang, M He, C Deng, H Wang, J Lian, XF Huang International Journal of Neuropsychopharmacology 17 (5), 807-818, 2014 | 60 | 2014 |
| Ameliorating antipsychotic-induced weight gain by betahistine: mechanisms and clinical implications J Lian, XF Huang, N Pai, C Deng Pharmacological Research 106, 51-63, 2016 | 54 | 2016 |
| Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: the role of histaminergic and NPY pathways J Lian, M De Santis, M He, C Deng Pharmacological research 95, 20-26, 2015 | 52 | 2015 |
| Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways X Liu, J Lian, CH Hu, C Deng Pharmacological research 100, 36-46, 2015 | 45 | 2015 |
| Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats X Liu, Z Wu, J Lian, CH Hu, XF Huang, C Deng Scientific Reports 7 (1), 2762, 2017 | 44 | 2017 |
| Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density J Lian, XF Huang, N Pai, C Deng Progress in Neuro-Psychopharmacology and Biological Psychiatry 47, 62-68, 2013 | 39 | 2013 |
| Unique effects of acute aripiprazole treatment on the dopamine D2 receptor downstream cAMP-PKA and Akt-GSK3β signalling pathways in rats B Pan, J Chen, J Lian, XF Huang, C Deng PloS one 10 (7), e0132722, 2015 | 31 | 2015 |
| Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats M De Santis, J Lian, XF Huang, C Deng Journal of Psychopharmacology 30 (2), 204-214, 2016 | 27 | 2016 |
| Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats B Pan, J Lian, XF Huang, C Deng Journal of Molecular Neuroscience 59 (1), 36-47, 2016 | 26 | 2016 |
| Prenatal poly I: C challenge affects behaviors and neurotransmission via elevated neuroinflammation responses in female juvenile rats Y Su, J Lian, J Hodgson, W Zhang, C Deng International Journal of Neuropsychopharmacology 25 (2), 160-171, 2022 | 24 | 2022 |
| Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats J Lian, B Pan, C Deng Pharmacological Reports 68 (5), 1028-1035, 2016 | 22 | 2016 |
| Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats M De Santis, B Pan, J Lian, XF Huang, C Deng Pharmacology Biochemistry and Behavior 124, 167-173, 2014 | 21 | 2014 |
| Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders Y Su, X Liu, J Lian, C Deng Pharmacological Research 155, 104703, 2020 | 18 | 2020 |
| Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D2 but not 5-HT2A/2C bindings in rat brains J Lian, XF Huang, N Pai, C Deng Progress in Neuro-Psychopharmacology and Biological Psychiatry 56, 75-80, 2015 | 15 | 2015 |
